You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma; liver cancer; cancer; liver

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B Virus Reactivation:Cautionary Event After Liver

Completed
  • Liver Transplant; Complications
  • Diagnosis of postoperative recurrence of liver cancer
  • (no location specified)
Oct 27, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

Not yet recruiting
  • Posto Perative Hepatocellular Carcinoma
  • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
  • (no location specified)
Feb 27, 2023

Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Population in Improving Eearly Diagnosis Efficancy in Chinese

Recruiting
  • Carcinoma, Hepatocellular
  • +4 more
  • Liver cancer surveillance every 3 months
  • +2 more
  • Shanghai, Shanghai, China
    Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
May 13, 2023

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

Not yet recruiting
  • Hepatocellular Carcinoma by BCLC Stage
  • Rennes, France
    Centre Eugene Marquis
Jan 16, 2023

Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial (Liquid Biopsy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Liquid Biopsy
  • (no location specified)
Apr 18, 2023

Detect and Expunge Concealed Tumors of the Liver

Recruiting
  • Liver Cancer
    • Hanoi, Vietnam
      108 Military Central Hospital
    Nov 15, 2023

    Vascular Invasion Signatures in cfDNA Support Re-staging of

    Completed
    • Carcinoma, Hepatocellular
    • +2 more
    • Liver resection
    • Shanghai, Shanghai, China
      Eastern Hepatobiliary Surgery Hospital, Naval Medical University
    Sep 15, 2022

    Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)

    Not yet recruiting
    • Liver Diseases
    • +4 more
    • bTAE-HAIC
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 30, 2023

    Incorporation of Protein Induced by Vitamin K Absence or

    Completed
    • Cancer of Liver
    • No intervention
    • Hangzhou, Zhejiang, China
      Affiliated Hangzhou First People's Hospital, Zhejiang University
    Jun 8, 2023

    Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

    Recruiting
    • Advanced Hepatocellular Carcinoma (HCC)
    • +2 more
    • Duarte, California
    • +2 more
    Aug 29, 2022

    Gender on Outcome of Liver Transplantation for Hepatocellular

    Completed
    • Cancer of Liver
    • no intervention
    • Hangzhou, Zhejiang, China
      Affiliated Hangzhou First People's Hospital, Zhejiang University
    Nov 29, 2022

    Prospective Cohort for Early Detection of Liver Cancer

    Recruiting
    • Cirrhosis
    • Hepatocellular Carcinoma
    • Blood and Urine samples
    • Oxford, Oxfordshire, United Kingdom
      Hepatology Clinical Trial Unit, John Radcliffe Hospital
    Sep 12, 2022

    Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)

    Not yet recruiting
    • Liver Diseases
    • +4 more
    • bTAE-HAIC
    • +2 more
    • Guanzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 24, 2023

    Hepatocellular Carcinoma Trial in Tianjin (Sintilimab, Bevacizumab, Liver Protective Support Therapy)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Nov 8, 2022

    Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)

    Not yet recruiting
    • Carcinoma, Hepatocellular
    • +3 more
    • GALAD
    • Liver Ultrasound with or without AFP
    • Los Angeles, California
    • +9 more
    Oct 18, 2023

    Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus

    Recruiting
    • Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
    • Atezolizumab plus bevacizumab
    • Seoul, Korea, Republic of
      Asan Medical Center
    Aug 7, 2023

    Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

    Active, not recruiting
    Has Results
    • Carcinoma, Hepatocellular
    • +3 more
    • Microwave ablation
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jan 23, 2023

    Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)

    Recruiting
    • Carcinoma, Hepatocellular
    • Liver Cell Carcinoma
    • New Brunswick, New Jersey
    • +1 more
    Sep 27, 2022

    d To Treat People With Hepatocellular Carcinoma

    Recruiting
    • Hepatocellular Cancer
    • Tokyo, Japan
      Takeda Selected Site
    Dec 5, 2022

    Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

    Recruiting
    • Advanced Cholangiocarcinoma
    • +6 more
    • Biospecimen Collection
    • +3 more
    • Los Angeles, California
    • +1 more
    Mar 31, 2023